Cities of the sea.
SpongeBob might make his home in a pineapple house, but about 25 percent of all marine animals live in coral reefs. The underwater cities are home to more than 250,000 known species, including more than 4,000 species of fish and 700 species of coral. Let's meet some of SpongeBob's...

ORASURE SUBMITS ORAQUICK HCV TEST PMA TO FDA.
OraSure Technologies, Inc. (NASDAQ: OSUR), Bethlehem, Penn., has submitted a pre-market approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for a rapid test for antibodies to the Hepatitis C virus ("HCV") utilizing OraSure Technologies' OraQuickR technology platform. When approved, the OraQuickR HCV test is expected to...

On the front line: nurses urged to get influenza vaccination.
It's been said that "nurses are the heartbeat of the health care system." Without them, the system could not survive. Sometimes, however, in their dedication to caring for others, nurses may forget to take care of themselves. This, too, can significantly burden the healthcare system, especially when...

Tibotec and Emcure Collaborate on Access to Darunavir for India.
COUNTY CORK, Ireland, Dec. 3 /PRNewswire/ -- Tibotec Pharmaceuticals today announced that it has signed a royalty-free, non-exclusive license agreement with Emcure Pharmaceuticals Limited of India to distribute the protease inhibitor darunavir (DRV) in India. Tibotec is committed to ensuring access to innovative HIV/AIDS therapies and has...

Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia.
CHICAGO, Dec. 3 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. , today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed the Company's New Drug Application (NDA) for cethromycin, a novel once-a-day oral antibiotic, for the treatment of mild-to-moderate community acquired pneumonia (CAP). The FDA...

New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome.
CHARLOTTE, N.C., Dec. 3 /PRNewswire/ -- The four million Americans who suffer from chronic fatigue syndrome (CFS) have new reason for hope today with the announcement of an unprecedented research program to help identify biomarkers for the illness and improve diagnosis and treatment of CFS. The announcement was made...

Flu's clues.
[ILLUSTRATION OMITTED] Ever wonder why the prime time for influenza-also known as the flu--is during the winter months? Scientists at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHHD) did. And now, they're closer to finding an answer. It seems that...

Food fright: are food-safety systems doing enough to keep us safe?
[ILLUSTRATION OMITTED] In July 2007, Larissa R., now 15, of South Weber, Utah, was having the time of her life at camp when a stomachache struck. "On the third night, my stomach started hurting so bad," she says. The next morning things were even worse. Larissa began...

Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza.
Partnership will accelerate research of potential vaccine for low-resource countries SEATTLE, and GAITHERSBURG, Md., Dec. 4 /PRNewswire/ -- The biotech company Lentigen Corporation and the nonprofit global health organization PATH announced today a partnership to accelerate research on a pandemic influenza vaccine. PATH will initially invest $3...

Southern Gardens Citrus Finalizing Plans to Begin Field Testing of Citrus Trees Resistant to Canker and Greening.
CLEWISTON, Fla., Dec. 4 /PRNewswire/ -- As part of its proactive program to deal with disease, Southern Gardens Citrus announced its plans to plant and field test canker and greening disease-resistant citrus trees in its groves starting in early 2009. Huanglongbing or citrus greening disease (HLB) is...